SME · NSE EmergeListed

Pramodini Medicare Ltd. IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 8:10 am IST · Source: Prospectus dated Mon 17 Aug 2026

Bid dates
Wed 12 Aug 2026 to Fri 14 Aug 2026
Listing date
Wed 19 Aug 2026
Issue price
₹118 per share

Listed on NSE on Wed 19 Aug 2026.

Listing price ₹120

Opening price on NSE on the listing day (ipocentral.in, as of Mon 16 Nov 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹118 per share
Prospectus dated Mon 17 Aug 2026, page 3
Lot size
1,200 shares
Prospectus dated Mon 17 Aug 2026, page 9
Issue size at the upper band
₹69.04 crore
Fresh issue
₹63.14 crore
Prospectus dated Mon 17 Aug 2026, page 1
Offer for sale
₹5.90 crore
Prospectus dated Mon 17 Aug 2026, page 1
Bid dates
Wed 12 Aug 2026 to Fri 14 Aug 2026
Prospectus dated Mon 17 Aug 2026, page 1
Listing date
Wed 19 Aug 2026
groww.in and ipocentral.in, as of Mon 16 Nov 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Mon 17 Aug 2026
Risk factors
89
Prospectus dated Mon 17 Aug 2026, page 63

Timeline (IST)

  1. OpensWed 12 Aug 2026, 10:00 am IST confirmedProspectus dated Mon 17 Aug 2026, page 1
  2. ClosesFri 14 Aug 2026 confirmedProspectus dated Mon 17 Aug 2026, page 1
  3. UPI mandate cut-offNot stated in the prospectus Prospectus dated Mon 17 Aug 2026
  4. AllotmentMon 17 Aug 2026 confirmedProspectus dated Mon 17 Aug 2026, page 359
  5. Refund and unblockTue 18 Aug 2026 by T+3 schedule
  6. Shares to dematTue 18 Aug 2026 by T+3 schedule
  7. ListingWed 19 Aug 2026 confirmedgroww.in and ipocentral.in, as of Mon 16 Nov 2026

Objects of the issue

ObjectAmount
Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres₹45.15 crore
General corporate purposes and unidentified inorganic acquisition₹10.76 crore
Total₹55.91 crore

The ₹5.90 crore offer for sale goes to the selling shareholders, not the company. Prospectus dated Mon 17 Aug 2026, page 100

Company and promoters

As described in the prospectus

We are a diagnostic service provider in India. We provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India.

Prospectus dated Mon 17 Aug 2026, page 138

Promoters

  • Sri Ram Medicare Private Limited
  • 4 individual promoters

Prospectus dated Mon 17 Aug 2026, page 196

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group85.71%62.64%

Prospectus dated Mon 17 Aug 2026, page 94

Financials (restated)

ItemMarch 31, 2026March 31, 2025March 31, 2024
Revenue from operations₹62.29 crore₹38.24 crore₹35.23 crore
Profit after tax₹17.38 crore₹11.03 crore₹6.93 crore
Net worth₹53.15 crore₹35.77 crore₹24.75 crore
Total borrowings₹17.85 crore₹10.81 crore₹11.96 crore

Prospectus dated Mon 17 Aug 2026, page 68

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual2,14,400₹2.53 crore
Individual shareholderIndividual1,43,000₹1.69 crore
M/S. Sri Ram Medicare Private LimitedCompany1,43,000₹1.69 crore
Total offer for sale₹5.90 crore

Figures may not add up due to rounding.

Prospectus dated Mon 17 Aug 2026, page 1

Peer comparison (as in the Prospectus)

Name of CompanyCMP (₹)Face Value (₹)Basic & Diluted EPS (₹)PE Ratio (times)RoNW (%)NAV per Share (₹)
Pramodini Medicare Limited1181010.4111.3432.69%31.84
Invicta Diagnostic Limited73.0010.004.9014.909.76%39.71
Krsnaa Diagnostics Limited575.305.0031.3018.3810.35%302.23
Star Imaging & Path Labs Limited95.5010.0011.058.6416.58%66.65

Reproduced from the Prospectus dated Mon 17 Aug 2026, page 111; InsightPier adds no figures

Risk factors

89 total
  1. Most revenue comes from government hospital partnerships (PPP) that may not be renewed or may pay late (offer document page 27)
  2. Heavy reliance on radiology services (offer document page 28)
  3. Most revenue comes from Andhra Pradesh (offer document page 28)
  4. A few key customers bring in most of the revenue (offer document page 29)
  5. Equipment orders for the capital expenditure are not yet placed, risking delays and cost overruns (offer document page 32)

All 89 risk factors, pages 27 to 63

Offer document

Allotment and bids

Registrar to the issue: Purva Sharegistry (India) Private Limited.

Allotment status is on the registrar's site, from Mon 17 Aug 2026. Pick "Pramodini Medicare Ltd." from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Overall––3.96×

ipocentral.in, as of Mon 16 Nov 2026

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts